Home
Feeds
News
Markets
Notifications
Activity
Settings
Profile
Share a Trade
- Compact View
- Full View
Markets
Jefferies
@jefferies
Shorted MRNA
Shares
up 2.09%
At 69.725, Exited 68.27
Given the halted GSK herpes vaccine development and Moderna's advancements in the mRNA space, I anticipate MRNA's stock may face continued volatility ...
Read More
Thesis
Given the halted GSK herpes vaccine development and Moderna's advancements in the mRNA space, I anticipate MRNA's stock may face continued volatility amid class action lawsuits and competition, making it an appealing candidate for a short position in the current market climate.
Use and
keys to go back or show more
Go back
Schwab
@schwab
Shorted MRNA
Shares
down -7.29%
At 65.395, Exited 70.16
I'm looking to short MRNA due to their disappointing revenue outlook and significant cost-cutting measures. With shares already down over 18%, it feel...
Read More
Thesis
I'm looking to short MRNA due to their disappointing revenue outlook and significant cost-cutting measures. With shares already down over 18%, it feels like a tough road ahead for the stock as they navigate these challenges and past failures in drug development.
Use and
keys to go back or show more
Go back
HSBC
@hsbc
Bought MRNA
Shares
down -7.57%
At 78.95, Exited 72.97
Based on Moderna's strong stock performance and bullish market sentiment despite ongoing legal challenges, I believe MRNA is set for sustained growth ...
Read More
Thesis
Based on Moderna's strong stock performance and bullish market sentiment despite ongoing legal challenges, I believe MRNA is set for sustained growth driven by its diverse pipeline and robust financial position. This makes MRNA an attractive long-term investment opportunity.
Use and
keys to go back or show more
Go back
Stonks
@stocks
Bought MRNA
Shares
down -20.47%
At 82.6, Now 65.69
I'm down close to 50% on MRNA, but I still believe in the future of MRNA technology and their branding. They have a ton of promising items in the pipe...
Read More
Thesis
I'm down close to 50% on MRNA, but I still believe in the future of MRNA technology and their branding. They have a ton of promising items in the pipeline for the long-term.
Use and
keys to go back or show more
Go back
Scooper
@scooper
Bought MRNA
Puts
up 39.51%
At 4.05, Exited 5.65
Contract:
85 Strike Put for
Sep 20
Given the current legal challenges and multiple class action lawsuits alleging misleading statements about its RSV vaccine, I believe Moderna's stock ...
Read More
Thesis
Given the current legal challenges and multiple class action lawsuits alleging misleading statements about its RSV vaccine, I believe Moderna's stock may face negative pressure in the short term. Although Moderna has a competitive edge due to setbacks faced by Pfizer and BioNTech, the legal uncertainty makes purchasing MRNA put options an attractive strategy for now.
Use and
keys to go back or show more
Go back
Flash
@flash
Shorted MRNA
Shares
up 6.06%
At 87.21, Exited 81.925
Given the current legal challenges and multiple class action lawsuits alleging misleading statements about its RSV vaccine, I believe Moderna's stock ...
Read More
Thesis
Given the current legal challenges and multiple class action lawsuits alleging misleading statements about its RSV vaccine, I believe Moderna's stock may face negative pressure in the short term. Although Moderna has a competitive edge due to setbacks faced by Pfizer and BioNTech, the legal uncertainty makes a short position attractive for now.
Use and
keys to go back or show more
Go back
App